• Transgen Bio’s reported group holding in Mgen Solutions fell to 16.01% from 20% as of October 22, 2026.
• Holdings declined by 175,000 to 4,961,306 shares and related instruments following Kang Yong-ju’s removal from the shareholder group on October 13.
• Voting shares held remained unchanged at 4,771,306; their ownership percentage fell to 15.4% from 18.58% as outstanding shares increased.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mgen Solutions Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261022000331), on October 22, 2026, and is solely responsible for the information contained therein.